VIRAL LOAD MONITORING – HEPATITIS C VIRUS (HCV) - ANVISA Registration 81062710024
Access comprehensive regulatory information for VIRAL LOAD MONITORING – HEPATITIS C VIRUS (HCV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81062710024 and manufactured by CEPHEID AB. The registration is held by Cepheid Brasil Importação, Exportação e Comércio de Produtos de Diagnósticos ltda with validity until Jul 31, 2027.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 4 companies making the same product including ABBOTT MOLECULAR INC, ROCHE MOLECULAR SYSTEMS, INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
81062710024
25351543031201608
18628083000123
Company Information
Dates and Status
Jul 31, 2017
31/07/2027
09/18/2025 19:00:01
MONITORAMENTO DE CARGA VIRAL – VÍRUS DE HEPATITE C (HCV)
HCV ELITe MGB Kit
Not specified
80686360403
Oct 30, 2023
MONITORAMENTO DE CARGA VIRAL – VÍRUS DE HEPATITE C (HCV)
HCV ELITe MGB Kit
ELITECH GROUP S.P.A
80686360403
Oct 30, 2023
MONITORAMENTO DE CARGA VIRAL – VÍRUS DE HEPATITE C (HCV)
artus HCV QS-RGQ
QIAGEN GMBH
10322250060
Sep 28, 2015
MONITORAMENTO DE CARGA VIRAL – VÍRUS DE HEPATITE C (HCV)
artus HCV QS-RGQ
Not specified
10322250060
Sep 28, 2015
MONITORAMENTO DE CARGA VIRAL – VÍRUS DE HEPATITE C (HCV)
COBAS® AmpliPrep/COBAS® TaqMan® HCV Quantitative Test, v2.0
Not specified
10287410995
Mar 04, 2013

